JP2023518228A5 - - Google Patents
Info
- Publication number
- JP2023518228A5 JP2023518228A5 JP2022555661A JP2022555661A JP2023518228A5 JP 2023518228 A5 JP2023518228 A5 JP 2023518228A5 JP 2022555661 A JP2022555661 A JP 2022555661A JP 2022555661 A JP2022555661 A JP 2022555661A JP 2023518228 A5 JP2023518228 A5 JP 2023518228A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- chain variable
- variable region
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025176983A JP2026031937A (ja) | 2020-03-17 | 2025-10-21 | 抗グリカン抗体及びそれらの使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062990927P | 2020-03-17 | 2020-03-17 | |
| US62/990,927 | 2020-03-17 | ||
| US202063037374P | 2020-06-10 | 2020-06-10 | |
| US63/037,374 | 2020-06-10 | ||
| US202063074956P | 2020-09-04 | 2020-09-04 | |
| US63/074,956 | 2020-09-04 | ||
| PCT/US2021/022627 WO2021188591A1 (en) | 2020-03-17 | 2021-03-16 | Anti-glycan antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025176983A Division JP2026031937A (ja) | 2020-03-17 | 2025-10-21 | 抗グリカン抗体及びそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518228A JP2023518228A (ja) | 2023-04-28 |
| JP2023518228A5 true JP2023518228A5 (https=) | 2024-03-27 |
Family
ID=75581605
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555661A Pending JP2023518228A (ja) | 2020-03-17 | 2021-03-16 | 抗グリカン抗体及びそれらの使用 |
| JP2025176983A Pending JP2026031937A (ja) | 2020-03-17 | 2025-10-21 | 抗グリカン抗体及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025176983A Pending JP2026031937A (ja) | 2020-03-17 | 2025-10-21 | 抗グリカン抗体及びそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11230608B2 (https=) |
| EP (1) | EP4121460A1 (https=) |
| JP (2) | JP2023518228A (https=) |
| KR (1) | KR20220155333A (https=) |
| CN (1) | CN115698082A (https=) |
| AU (1) | AU2021237566A1 (https=) |
| CA (1) | CA3170434A1 (https=) |
| WO (1) | WO2021188591A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023133452A1 (en) * | 2022-01-06 | 2023-07-13 | PTM Therapeutics, Inc. | Methods of treating solid tumors and compositions thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| WO2013078425A1 (en) * | 2011-11-22 | 2013-05-30 | University Of Maryland, Baltimore | Lambodies with high affinity and selectivity for glycans and uses therefor |
-
2021
- 2021-03-16 EP EP21720042.7A patent/EP4121460A1/en active Pending
- 2021-03-16 WO PCT/US2021/022627 patent/WO2021188591A1/en not_active Ceased
- 2021-03-16 JP JP2022555661A patent/JP2023518228A/ja active Pending
- 2021-03-16 AU AU2021237566A patent/AU2021237566A1/en active Pending
- 2021-03-16 KR KR1020227035436A patent/KR20220155333A/ko active Pending
- 2021-03-16 CN CN202180021642.8A patent/CN115698082A/zh active Pending
- 2021-03-16 CA CA3170434A patent/CA3170434A1/en active Pending
- 2021-03-16 US US17/203,650 patent/US11230608B2/en active Active
- 2021-12-09 US US17/547,101 patent/US20220340683A1/en not_active Abandoned
-
2024
- 2024-08-13 US US18/802,976 patent/US20250034276A1/en active Pending
-
2025
- 2025-10-21 JP JP2025176983A patent/JP2026031937A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022079549A5 (https=) | ||
| JP2009517057A5 (https=) | ||
| JP2021525546A5 (https=) | ||
| JP2012501670A5 (https=) | ||
| RU2008129111A (ru) | Антитела к ox40l и способы их применения | |
| RU2009128064A (ru) | Антитела к cd44 | |
| RU2015115956A (ru) | Антитела, специфичные в отношении фактора роста тромбоцитов в, и их композиции и применения | |
| JP2015502138A5 (https=) | ||
| JP2012524071A5 (https=) | ||
| JP2009518039A5 (https=) | ||
| JP2020534830A5 (https=) | ||
| JP2011207882A5 (https=) | ||
| RU2011103125A (ru) | КОМБИНАЦИЯ АНТАГОНИСТА c-Met И АМИНОГЕТЕРОАРИЛА ДЛЯ ЛЕЧЕНИЯ РАКА | |
| RU2012103212A (ru) | Tlr3 связывающие агенты | |
| JP2013509158A5 (https=) | ||
| JP2024086870A5 (https=) | ||
| JP2024520188A5 (https=) | ||
| JP2020534012A5 (https=) | ||
| JP2010514459A5 (https=) | ||
| JP2023549555A5 (https=) | ||
| WO2023131193A1 (zh) | 靶向人b7-h3分子的人源化单克隆抗体及其应用 | |
| RU2008140947A (ru) | Антитела к egfl7 и способы их применения | |
| JP2023506465A5 (https=) | ||
| JP2019513410A5 (https=) | ||
| JP2020522488A5 (https=) |